| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |